{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:54:04Z","timestamp":1788926044584,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The incidence of chronic obstructive pulmonary disease (COPD) and non-alcoholic fatty liver disease (NAFLD) has increased significantly in past decades, posing a significant public health burden. An increasing amount of research points to a connection between COPD and NAFLD. This study aimed to identify the key genes of these two diseases, construct a diagnostic model, and predict potential therapeutic agents based on critical genes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>NAFLD and COPD datasets were obtained from the GEO database, differential genes were identified by differential analysis and WGCNA, PPI networks were constructed and enriched for differential genes and COPD-associated secreted proteins, small molecule compounds were screened, and immune cell infiltration was assessed. Meanwhile, LASSO and RF further screened the essential genes, and finally, two key genes were obtained. Subsequently, the nomogram diagnostic model and lncRNA-miRNA-mRNA network were constructed based on these two core genes, subjected to drug prediction and GSEA enrichment analysis, and validated in an external cohort using qRT-PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>KEGG enrichment analysis indicated that the NF-kappa B and TNF signaling pathways may be associated with COPD and NASH co-morbidities. Ten small-molecule drugs associated with COPD and NASH were identified through cMAP analysis, including ansoprazole and atovaquone. In addition, we further identified the hub genes S100A9 and MYH2 for NAFLD and COPD by machine learning methods. The immune infiltration indicated that these two core genes might be involved in the immunomodulatory process of NASH by regulating the function or recruitment of specific immune cell types. A nomogram diagnostic model was constructed based on these two core genes. The AUC value for S100A9 was 0.887, for MYH2 was 0.877, and for the nomogram was 0.889, demonstrating excellent diagnostic efficacy. Two hundred fifty-four potential drugs targeting S100A9 and 67 MYH2 were searched in the DGIdb database. Meanwhile, the lncRNA-miRNA-mRNA network was constructed by predicting target miRNAs of biomarkers and further predicting lncRNAs targeting miRNAs. qRT-PCR analysis revealed that S100A9 was upregulated in both COPD and NAFLD, consistent with bioinformatic predictions, while MYH2 showed increased expression in COPD but decreased expression in NAFLD, diverging from the predicted downregulation in both diseases. These findings suggest that S100A9 serves as a common inflammatory marker for both diseases, whereas MYH2 may be regulated by disease-specific mechanisms, highlighting its potential for distinguishing COPD from NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The hub genes S100A9 and MYH2 in COPD and NASH were identified by various bioinformatics methods and a diagnostic model was constructed to improve the diagnostic efficiency. We also revealed some potential biological mechanisms of COPD and NASH and potential drugs for COPD-related NASH. Our findings provide potential new diagnostic and therapeutic options for COPD-associated NASH and may help reduce its prevalence.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1514422","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:11:54Z","timestamp":1740719514000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO"],"prefix":"10.3389","volume":"16","author":[{"given":"Jianwei","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangrui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishuai","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00470-6","article-title":"Chronic obstructive pulmonary disease","volume":"399","author":"Christenson","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.13416","article-title":"Clinical guideline highlights for the hospitalist: GOLD COPD update 2024","volume":"19","author":"Cornelius","year":"2024","journal-title":"J Hosp Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S2213-2600(21)00506-3","article-title":"Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment","volume":"10","author":"Yang","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404615","article-title":"Inflammation mechanism and research progress of COPD","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28584","article-title":"Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Lonardo","year":"2016","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2018-136316","article-title":"Diagnosis and management of non-alcoholic fatty liver disease","volume":"95","author":"Jennison","year":"2019","journal-title":"Postgrad Med J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/nu15051123","article-title":"The inter-organ crosstalk reveals an inevitable link between MAFLD and extrahepatic diseases","volume":"15","author":"Tsutsumi","year":"2023","journal-title":"Nutrients"},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11892-021-01383-7","article-title":"The relationship between type 2 diabetes, NAFLD, and cardiovascular risk","volume":"21","author":"Caussy","year":"2021","journal-title":"Curr Diabetes Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21545","article-title":"Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation","volume":"14","author":"Rybak","year":"2008","journal-title":"Liver Transpl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1700546","DOI":"10.1183\/13993003.00546-2017","article-title":"Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm","volume":"49","author":"Lonardo","year":"2017","journal-title":"Eur Respir J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.3948","article-title":"High COPD prevalence in patients with liver disease","volume":"49","author":"Minakata","year":"2010","journal-title":"Intern Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2019.07.008","article-title":"Extra-hepatic manifestations of nonalcoholic fatty liver disease: a review","volume":"10","author":"Tariq","year":"2020","journal-title":"J Clin Exp Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1601923","DOI":"10.1183\/13993003.01923-2016","article-title":"Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease","volume":"49","author":"Viglino","year":"2017","journal-title":"Eur Respir J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00148014","article-title":"Does COPD stand for \"comorbidity with pulmonary disease\"","volume":"45","author":"Vanfleteren","year":"2015","journal-title":"Eur Respir J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","article-title":"A guide to machine learning for biologists","volume":"23","author":"Greener","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15195","article-title":"Risk of hepatic and extrahepatic cancer in NAFLD: a population-based cohort study","volume":"42","author":"Bjorkstrom","year":"2022","journal-title":"Liver Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.canlet.2015.09.005","article-title":"A pro-tumorigenic function of S100A8\/A9 in carcinogen-induced hepatocellular carcinoma","volume":"369","author":"De Ponti","year":"2015","journal-title":"Cancer Letters"},{"key":"B25","doi-asserted-by":"publisher","first-page":"188891","DOI":"10.1016\/j.bbcan.2023.188891","article-title":"S100A8 and S100A9 in cancer","volume":"1878","author":"Chen","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-021-01168-9","article-title":"Filamentous tangles with nemaline rods in MYH2 myopathy: a novel phenotype","volume":"9","author":"Madigan","year":"2021","journal-title":"Acta Neuropathologica Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1320","article-title":"MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form","volume":"8","author":"Telese","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"10822","DOI":"10.1038\/s41598-024-61696-x","article-title":"Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults","volume":"14","author":"Zheng","year":"2024","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2022.03.201412","article-title":"Respiratory diseases and obesity: special phenotype or independent events: Review","volume":"94","author":"Shchepikhin","year":"2022","journal-title":"Terapevticheskii arkhiv"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101167","article-title":"Imaging biomarkers of NAFLD, NASH, and fibrosis","volume":"50","author":"Ajmera","year":"2021","journal-title":"Mol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-012-1024-2","article-title":"Myosinopathies: pathology and mechanisms","volume":"125","author":"Tajsharghi","year":"2012","journal-title":"Acta Neuropathologica"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076454","article-title":"Main pathogenic mechanisms and recent advances in COPD peripheral skeletal muscle wasting","volume":"24","author":"Henrot","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00104","article-title":"Structural alterations of skeletal muscle in copd","volume":"5","author":"Mathur","year":"2014","journal-title":"Front Physiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.985523","article-title":"S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation","volume":"123","author":"Averill","year":"2011","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019375","article-title":"S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE)","volume":"6","author":"Jin","year":"2011","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7150\/thno.67174","article-title":"Overexpression of S100A9 in obesity impairs macrophage differentiation via TLR4-NFkB-signaling worsening inflammation and wound healing","volume":"12","author":"Franz","year":"2022","journal-title":"Theranostics"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127352","article-title":"S100A9: a potential biomarker for the progression of non-alcoholic fatty liver disease and the diagnosis of non-alcoholic steatohepatitis","volume":"10","author":"Liu","year":"2015","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00207.2020","article-title":"Cigarette smoke induction of S100A9 contributes to chronic obstructive pulmonary disease","volume":"319","author":"Railwah","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3233\/JND-230017","article-title":"MYH2-related myopathy: expanding the clinical spectrum of chronic progressive external ophthalmoplegia (CPEO)","volume":"10","author":"Baskar","year":"2023","journal-title":"J Neuromuscular Diseases"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S249534","article-title":"Sarcopenia is an independent risk factor for NAFLD in COPD: a nationwide survey (KNHANES 2008-2011)","volume":"15","author":"Hong","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12291-020-00932-3","article-title":"Association of promoter methylation and expression of inflammatory genes IL-6 and TNF-\u03b1 with the risk of coronary artery disease in diabetic and obese subjects among asian Indians","volume":"37","author":"Indumathi","year":"2020","journal-title":"Indian J Clin Biochem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2456-x","article-title":"The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes","volume":"55","author":"Giebelstein","year":"2012","journal-title":"Diabetologia"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1252","article-title":"Systemic manifestations of COPD","volume":"139","author":"Nussbaumer-Ochsner","year":"2011","journal-title":"Chest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1514422\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:11:57Z","timestamp":1740719517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1514422\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2025.1514422"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1514422","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"article-number":"1514422"}}